![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JF Puig and TR Tephly
A UDP-glucuronosyltransferase (UDPGT) isoenzyme capable of morphine glucuronidation has been purified to apparent homogeneity and partially characterized from hepatic microsomes of female Wistar rats which have low 3 alpha-hydroxysteroid UDPGT. A rapid and sensitive assay was developed to quantify morphine glucuronide formation using 14C-UDP- glucuronic acid and reverse phase C-18 minicolumns whereby radioactive glucuronides were differentially eluted from 14C-UDP-glucuronic acid. Trisacryl-DEAE and chromatofocusing chromatographic procedures were employed to separate and purify morphine UDPGT in the presence of exogenous phosphatidylcholine. The addition of phospholipid was necessary to stabilize UDPGT activities throughout the purification procedures. Morphine UDPGT was isolated to apparent homogeneity and displayed a pl of 7.9 upon chromatofocusing. A monomeric molecular weight of 56,000 was obtained. The purified enzyme reacted with morphine but not with 4-hydroxybiphenyl, p-nitrophenol, testosterone, androsterone, estrone, bilirubin, 4-aminobiphenyl, or alpha- naphthylamine. The MgCl2 requirement for maximal expression of morphine glucuronidation was higher for the purified enzyme than for solubilized and intact microsomes. Codeine competitively inhibits morphine glucuronidation with an apparent Ki of 1.1 mM with the purified morphine UDPGT. 4-Hydroxybiphenyl UDPGT was separated from morphine UDPGT using a chromatofocusing procedure for Emulgen 911-solubilized microsomes. An apparent pl value of 5.5 was obtained for this protein. Based on this work we conclude that morphine and 4-hydroxybiphenyl can react with separate UDPGT isoforms.
This article has been cited by other articles:
|
|
 |
|
  L. Antonilli, C. Suriano, G. Paolone, A. Badiani, and P. Nencini Repeated Exposures to Heroin and/or Cadmium Alter the Rate of Formation of Morphine Glucuronides in the Rat J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 651 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Rios and T. R. Tephly Inhibition and Active Sites of UDP-Glucuronosyltransferases 2B7 and 1A1. Drug Metab. Dispos., December 1, 2002; 30(12): 1364 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ishii, A. Miyoshi, R. Watanabe, K. Tsuruda, M. Tsuda, Y. Yamaguchi-Nagamatsu, K. Yoshisue, M. Tanaka, D. Maji, S. Ohgiya, et al. Simultaneous Expression of Guinea Pig UDP-Glucuronosyltransferase 2B21 and 2B22 in COS-7 Cells enhances UDP-Glucuronosyltransferase 2B21-Catalyzed Morphine-6-Glucuronide Formation Mol. Pharmacol., November 1, 2001; 60(5): 1040 - 1048. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. King, W. Tang, J. Ngui, T. Tephly, and M. Braun Characterization of Rat and Human UDP-Glucuronosyltransferases Responsible for the in Vitro Glucuronidation of Diclofenac Toxicol. Sci., May 1, 2001; 61(1): 49 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. King, B. Finley, and R. Franklin The Glucuronidation of Morphine by Dog Liver Microsomes: Identification of Morphine-6-O-Glucuronide Drug Metab. Dispos., June 1, 2000; 28(6): 661 - 663. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Cheng, A. Radominska-Pandya, and T. R. Tephly Studies on the Substrate Specificity of Human Intestinal UDP-Glucuronosyltransferases 1A8 and 1A10 Drug Metab. Dispos., October 1, 1999; 27(10): 1165 - 1170. [Abstract] [Full Text]
|
|
|
|
 |
|
 O. Evans and D. O'Reilly Expression and structural characterization of a baculovirus ecdysteroid UDP-glucosyltransferase J. Gen. Virol., February 1, 1999; 80(2): 485 - 492. [Abstract]
|
|
|
|
|
|
M. D. Green and T. R. Tephly Glucuronidation of Amine Substrates by Purified and Expressed UDP-Glucuronosyltransferase Proteins Drug Metab. Dispos., September 1, 1998; 26(9): 860 - 867. [Abstract] [Full Text]
|
|
|
|
|
|
M. D. Green, C. D. King, B. Mojarrabi, P. I. Mackenzie, and T. R. Tephly Glucuronidation of Amines and Other Xenobiotics Catalyzed by Expressed Human UDP-Glucuronosyltransferase 1A3 Drug Metab. Dispos., June 1, 1998; 26(6): 507 - 512. [Abstract] [Full Text]
|
|
|
|
|
|
B. L. Coffman, C. D. King, G. R. Rios, and T. R. Tephly The Glucuronidation of Opioids, Other Xenobiotics, and Androgens by Human UGT2B7Y(268) and UGT2B7H(268) Drug Metab. Dispos., January 1, 1998; 26(1): 73 - 77. [Abstract] [Full Text]
|
|
|
|
|
|
M. D. Green, G. Bélanger, D. W. Hum, A. Bélanger, and T. R. Tephly Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein Drug Metab. Dispos., December 1, 1997; 25(12): 1389 - 1394. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Ishii, A. Takami, K. Tsuruda, A. Kurogi, H. Yamada, and K. Oguri Induction of Two UDP-Glucuronosyltransferase Isoforms Sensitive to Phenobarbital that are Involved in Morphine Glucuronidation. Production of Isoform-Selective Antipeptide Antibodies toward UGT1.1r and UGT2B1 Drug Metab. Dispos., February 1, 1997; 25(2): 163 - 167. [Abstract] [Full Text]
|
|
|
|
|
|
C. D. King, G. R. Rios, M. D. Green, P. I. Mackenzie, and T. R. Tephly Comparison of Stably Expressed Rat UGT1.1 and UGT2B1 in the Glucuronidation of Opioid Compounds Drug Metab. Dispos., February 1, 1997; 25(2): 251 - 255. [Abstract] [Full Text]
|
|
|
|
|
|
B. L. Coffman, G. R. Rios, C. D. King, and T. R. Tephly Human UGT2B7 Catalyzes Morphine Glucuronidation Drug Metab. Dispos., January 1, 1997; 25(1): 1 - 4. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
